HTG Molecular Diagnostics (HTGM) Set to Announce Quarterly Earnings on Monday

HTG Molecular Diagnostics (NASDAQ:HTGM) will be announcing its earnings results after the market closes on Monday, May 14th.

HTG Molecular Diagnostics (NASDAQ:HTGM) last released its earnings results on Thursday, March 22nd. The medical research company reported ($0.15) EPS for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.15. The firm had revenue of $7.90 million for the quarter, compared to the consensus estimate of $7.05 million.

NASDAQ HTGM opened at $3.68 on Monday. HTG Molecular Diagnostics has a 12 month low of $1.59 and a 12 month high of $5.83. The company has a market cap of $104.35, a price-to-earnings ratio of -2.06 and a beta of 1.61.

HTGM has been the topic of a number of recent analyst reports. Zacks Investment Research cut shares of HTG Molecular Diagnostics from a “buy” rating to a “sell” rating in a research note on Wednesday, March 28th. HC Wainwright restated a “buy” rating and set a $6.00 target price on shares of HTG Molecular Diagnostics in a research note on Thursday, February 1st. ValuEngine upgraded shares of HTG Molecular Diagnostics from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. Finally, Canaccord Genuity raised their target price on shares of HTG Molecular Diagnostics from $5.00 to $7.00 and gave the stock a “buy” rating in a research note on Friday, March 23rd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $6.56.

About HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc develops and markets products and services based on proprietary technology that facilitates the routine use of targeted molecular profiling. The company's products, HTG Edge and HTG EdgeSeq platforms include instrumentation (or platforms), consumables comprising assay kits, and software analytics that automate sample processing and profiles various molecular targets from samples a fraction of the size required by prevailing technologies.

Earnings History for HTG Molecular Diagnostics (NASDAQ:HTGM)

Receive News & Ratings for HTG Molecular Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HTG Molecular Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Artisan Partners Asset  Given Daily News Sentiment Rating of 0.36
Artisan Partners Asset Given Daily News Sentiment Rating of 0.36
Pan American Silver  Getting Somewhat Favorable Press Coverage, Analysis Shows
Pan American Silver Getting Somewhat Favorable Press Coverage, Analysis Shows
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Commercial Metals  Share Price
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Commercial Metals Share Price
Oppenheimer Weighs in on BioLineRx’s FY2021 Earnings
Oppenheimer Weighs in on BioLineRx’s FY2021 Earnings
Q1 2020 EPS Estimates for Kohl’s Boosted by Analyst
Q1 2020 EPS Estimates for Kohl’s Boosted by Analyst
JPMorgan Chase & Co. Cuts AutoZone  Price Target to $800.00
JPMorgan Chase & Co. Cuts AutoZone Price Target to $800.00


© 2006-2018 Ticker Report. Google+.